Results 111 to 120 of about 15,631 (257)

Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease

open access: yesMolecular Genetics and Metabolism Reports, 2017
Background: Early initiation of enzyme replacement therapy (ERT) with recombinant human acid alpha-glucosidase is an effective treatment for patients with infantile-onset Pompe disease (IOPD) but cannot prevent a slow progression of myopathy.
Yin-Hsiu Chien   +7 more
doaj   +1 more source

Effects of flow rate on transnasal pulmonary aerosol delivery of bronchodilators via high-flow nasal cannula for patients with COPD and asthma: protocol for a randomised controlled trial

open access: yesBMJ Open, 2019
IntroductionBoth in vitro and in vivo radiolabelled studies on nebulisation via high-flow nasal cannula showed that inhaled dose decreases as the administered gas flow increases. In our previous in vitro study, we investigated the effects of the ratio of
Jian Luo   +3 more
doaj   +1 more source

Anticholinergic therapy for acute asthma in children. [PDF]

open access: yes, 2012
Inhaled anticholinergics as single agent bronchodilators (or in combination with beta(2)-agonists) are one of the several medications available for the treatment of acute asthma in ...
Beakes   +49 more
core   +2 more sources

Intentional salbutamol poisoning: report of two siblings and review of the literature

open access: yesSaudi Journal of Emergency Medicine
Background: About 65% of poisoning cases are related to children and of these, more than half of the patients are 5-year-old or less. While non-accidental poisoning is rare.
Dana Altamimi   +2 more
doaj   +1 more source

For COPD a Combination of Ipratropium Bromide and Albuterol Sulfate Is More Effective Than Albuterol Base [PDF]

open access: yesArchives of Internal Medicine, 1999
A combination metered-dose inhaler aerosol containing ipratropium bromide and albuterol sulfate has been reported to be more effective than either of its components in patients with chronic obstructive pulmonary disease. The dose of albuterol sulfate is equal in moles per liter to the dose of albuterol base used in the commercially available metered ...
openaire   +3 more sources

Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors [PDF]

open access: yes, 2011
Background There are limited data assessing bronchodilator responsiveness (BDR) in infants and toddlers with recurrent wheezing, and factors associated with a positive response.
Debley, Jason   +3 more
core   +1 more source

Polyphenol Intake During Pregnancy and Childhood Asthma and Atopic Disorders: A Systematic Review

open access: yes
Clinical &Experimental Allergy, Volume 55, Issue 7, Page 567-570, July 2025.
Rachel J. Morgan   +6 more
wiley   +1 more source

COPD: Optimizing Treatment [PDF]

open access: yes, 2015
A guideline update and an expanded armamentarium have many physicians wondering how best to treat patients with COPD. Chronic obstructive pulmonary disease (COPD) carries a high disease burden. In 2012, it was the 4th leading cause of death worldwide.1,2
Ahmed-Sarwar, Nabila   +2 more
core   +1 more source

Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma [PDF]

open access: yes, 2011
Asthma patients who continue to experience symptoms despite being on regular inhaled corticosteroids (ICS) represent a management challenge. Long-acting beta2-agonists (LABA) or anti-leukotrienes (LTRA) are two treatment options that could be considered ...
Adams   +207 more
core   +1 more source

Comparison of albuterol sulphate and base dry powder particulate deposition using the Calu-3 lung epithelial model [PDF]

open access: yes, 2011
To effectively predict the fate of formulated inhalation compounds delivered to the lung, a model of the airway epithelium should reflect drug permeability and transport characteristics in vivo.
Bebawy, M, Haghi, M, Traini, D, Young, P
core  

Home - About - Disclaimer - Privacy